SJK TECHNOLOGIES LIMITED

Company number 07300024 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Score: A- (Excellent with minor symptoms of strain)

Explanation: SJK Technologies Limited is a robust and financially sound patient. It has successfully recovered from a period of significant distress in its early years (negative net assets in 2017/2018) to build a strong foundation of reserves. However, the recent slight decline in overall net assets, combined with a sudden spike in short-term liabilities, prevents a perfect score. While the company's "immunity" (liquidity) is incredibly strong, the sudden shift in liabilities is a mild symptom that requires monitoring.


1. Key Vital Signs (Critical Metrics & Interpretation)

  • Net Assets (The "Body Mass"): £157,182 (Down from £166,785 in 2024)
    • Interpretation: The company is in a healthy weight class, having grown significantly from a dangerously low point in 2017/2018. However, the recent slight drop indicates that the business is either consuming its reserves or extracting value (likely through dividends), rather than retaining all earned profits.
  • Current Ratio (The "Circulation System"): 6.27x (Current Assets £174,333 / Current Liabilities £27,775)
    • Interpretation: Outstanding. A healthy circulatory system ensures you can meet short-term obligations without breaking a sweat. For every £1 owed in the short term, the company has £6.27 in liquid assets. This indicates zero risk of a short-term "cardiac arrest" (cash flow crisis).
  • Liability Burden (The "Cholesterol Levels"): £27,775 (Up from £9,127 in 2024)
    • Interpretation: Total liabilities are still very low relative to assets, meaning the company has low financial cholesterol. However, the roughly 200% increase in short-term creditors in just one year is a sudden spike that needs diagnosis.
  • Fixed Assets (The "Musculoskeletal System"): £10,624 (Up from £9,689 in 2024)
    • Interpretation: The company is lightly capitalized in terms of physical infrastructure. It relies heavily on its current assets (likely cash and receivables) rather than heavy equipment, which is typical for a business support services firm.

2. Symptoms Analysis (What the Numbers Reveal)

Looking at the patient's history, we see a dramatic recovery. In 2017, the company had negative net assets of -£45,738—a state of severe financial malnutrition. By 2023, it had built up reserves of £177,230. This is a testament to strong operational "metabolism" (profitability).

However, the most recent fiscal year (ending March 2025) presents an interesting symptom: a decline in net assets despite reported profitability.

The director's report explicitly states the company is experiencing "good levels of sales growth and profitability." If the company is profitable, net assets should naturally increase unless value is being extracted. The simultaneous drop in net assets (£166,785 down to £157,182) and the significant increase in current liabilities (£9,127 up to £27,775) strongly suggest that the directors have declared a dividend payout. The increase in creditors may also indicate a timing difference in paying trade expenses or an accrual for the dividend itself or corporation tax.


3. Diagnosis (Overall Financial Condition)

Diagnosis: Healthy, but experiencing controlled bleeding (dividends/distributions).

The underlying business is fundamentally sound and highly liquid. The patient is not at risk of collapse. However, the financial vital signs show that the business is not retaining its earnings to the same extent it did during the 2019-2023 growth phase. The "bleeding" of net assets is intentional (presumably rewarding the shareholders) rather than a symptom of operational loss, but it does mean the company's financial cushion is slightly shrinking. Additionally, the jump in short-term creditors means more cash will be required to settle bills in the near future than in the previous year.


4. Prognosis & Recommendations (Future Outlook & Actions)

Prognosis: Positive. The company's exceptional liquidity provides a massive buffer against economic shocks. As long as revenue generation remains stable, the business is well-positioned to survive and thrive.

Recommendations to Improve Financial Wellness:

  1. Monitor the Liability Spike: Investigate the cause of the £18,648 increase in short-term creditors. If it is a one-off accrual (like a dividend or tax payment), no action is needed. If it represents a trend of relying on trade credit to fund operations, it must be curtailed before it restricts cash flow.
  2. Maintain a "Healthy Weight" for Retained Earnings: While extracting profits as dividends is the reward for business ownership, ensure that a portion of "good cholesterol" (retained profits) is kept inside the business to fund future working capital and protect against unforeseen downturns.
  3. Reinvest in "Muscle": With only £10,624 in fixed assets, consider whether reinvesting in technology, software, or equipment could drive operational efficiency and future growth, rather than relying solely on the existing asset base.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 7 September 2026